IfW advises a long-standing client on the acquisition of a company in the medical technology sector. The company manufactures long-term stents, which are a minimally invasive, reversible alternative solution - as opposed to the common practice of invasive or short-term solutions.
The company is based in Israel and sells its products worldwide.
The transaction was negotiated exclusively. IfW advised the buyer in all phases of the purchase process.